Premium
Hollow Structure Improved Anti‐Cancer Immunity of Mesoporous Silica Nanospheres In Vivo
Author(s) -
Wang Xiupeng,
Li Xia,
Ito Atsuo,
Yoshiyuki Kazuko,
Sogo Yu,
Watanabe Yohei,
Yamazaki Atsushi,
Ohno Tadao,
Tsuji Noriko M.
Publication year - 2016
Publication title -
small
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.785
H-Index - 236
eISSN - 1613-6829
pISSN - 1613-6810
DOI - 10.1002/smll.201600677
Subject(s) - in vivo , mesoporous silica , mesoporous material , nanotechnology , immunity , cancer , in vitro , materials science , splenocyte , cancer immunotherapy , chemistry , immunotherapy , biology , immune system , immunology , biochemistry , microbiology and biotechnology , catalysis , genetics
Hollow and non‐hollow mesoporous silica nanospheres are synthesized and used for cancer vaccine adjuvants. The hollow structure of mesoporous silica nanospheres significantly promote cellular uptake of a model cancer antigen by macrophage‐like cells in vitro, improve anti‐cancer immunity, CD4 + and CD8 + T cell populations in splenocytes of mice in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom